Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|11|4|435-455
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.11, Iss.4, 2005-02, pp. : 435-455
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart Failure
Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. :
Access to resources
Recommend
Levosimendan Use Reduces Matrix Metalloproteinase-2 in Patients with Decompensated Heart Failure
By Tziakas Dimitrios Chalikias Georgios Hatzinikolaou Helen Stakos Dimitrios Papanas Nikolaos Tentes Ioannis Kortsaris Alexandros Maltezos Efstratios Hatseras Dimitrios Kaski Juan
Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. :
Levosimendan: A Review of its Use in the Management of Acute Decompensated Heart Failure
Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. :
Doxorubicin: Decompensated heart failure treated with levosimendan: case report
Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. :